CJC-1295 DAC Storage & Stability
Maintaining structural integrity and preventing enzymatic or chemical degradation is vital when conducting preclinical trials with growth factor analogs. CJC-1295 DAC requires strict thermal and environmental management during storage, reconstitution, and laboratory handling. This technical protocol outlines temperature thresholds, solvent selection, and degradation pathways to preserve peptide potency across extended research timelines.
Quick answer
Maintaining structural integrity and preventing enzymatic or chemical degradation is vital when conducting preclinical trials with growth factor analogs. CJC-1295 DAC requires strict thermal and environmental management during storage, reconstitution, and laboratory handling. This technical protocol outlines temperature thresholds, solvent selection, and degradation pathways to preserve peptide potency across extended research timelines.
Key takeaways
- [CJC-1295](/research-peptides/cjc-1295-no-dac) DAC is a synthetic analog of growth hormone-releasing hormone (GHRH) designed with a tetra-substituted 29-amino acid sequence coupled to a Drug Affinity Complex (DAC) moiety.
- The core molecule of [CJC-1295](/research-peptides/cjc-1295-no-dac) is modified with a maleimidopropionic acid (MPA) linker attached via a lysine residue at the C-terminus.
- In its native lyophilized state, [research peptides](/research) exhibit enhanced chemical stability due to the removal of aqueous phase water, which serves as a primary substrate for hydrolytic reactions.
- Reconstitution transitions the peptide from a dormant solid matrix to an active aqueous state, drastically increasing its susceptibility to thermal and chemical degradation.
Introduction to CJC-1295 DAC Storage Mechanics
CJC-1295 DAC is a synthetic analog of growth hormone-releasing hormone (GHRH) designed with a tetra-substituted 29-amino acid sequence coupled to a Drug Affinity Complex (DAC) moiety. In preclinical models, this bioconjugated peptide is studied as a long-acting growth-hormone-releasing hormone that sustains GH and downstream IGF-1 levels for tissue repair research. Because peptide degradation directly impacts binding affinity at the GHRH receptor, maintaining precise storage parameters is essential to ensure consistent, reproducible assay outcomes.
Like most complex synthetic peptides, CJC-1295 DAC is prone to specific physical and chemical degradation processes, including hydrolysis, oxidation, and deamidation. Exposure to thermal fluctuations, ambient light, moisture, or improper reconstituted solvents accelerates these breakdown pathways. Establishing a rigorous cold-chain standard from receipt through experimental utilization safeguards the sequence integrity required for analytical rigor.
Molecular Structure and the Role of the DAC Modality
The core molecule of CJC-1295 is modified with a maleimidopropionic acid (MPA) linker attached via a lysine residue at the C-terminus. This specific chemical addition constitutes the Drug Affinity Complex (DAC). In vivo preclinical research demonstrates that this reactive linker covalently binds to circulating serum albumin, forming a bioconjugate that resists rapid renal clearance and enzymatic degradation by dipeptidyl peptidase-4 (DPP-IV).
While the DAC modification grants remarkable biological persistence in animal models, the unreacted maleimide group present in the lyophilized raw compound is reactive. Prior to reconstitution and introduction to albumin-containing media, the maleimide ring can undergo slow hydrolytic ring-opening or non-specific nucleophilic reactions if exposed to excessive heat or ambient moisture. Understanding the dual nature of this structure underscores the importance of stringent dry, low-temperature handling protocols in the laboratory.
Lyophilized Powder Storage Protocols and Thermal Thresholds
In its native lyophilized state, research peptides exhibit enhanced chemical stability due to the removal of aqueous phase water, which serves as a primary substrate for hydrolytic reactions. However, optimal storage conditions remain necessary to preserve long-term integrity over extended laboratory timelines.
For short-term storage (under 30 days), lyophilized CJC-1295 DAC should be maintained between 2°C and 8°C in a dry environment. For long-term storage exceeding one month, laboratory guidelines dictate preserving the lyophilized vial at -20°C or lower (ideally -80°C in an ultra-low temperature freezer). Desiccant pouches should be maintained within secondary storage containers to counteract ambient humidity, preventing moisture absorption upon thawing or during routine freezer maintenance cycles.
Reconstitution Protocols and Solvent Compatibility
Reconstitution transitions the peptide from a dormant solid matrix to an active aqueous state, drastically increasing its susceptibility to thermal and chemical degradation. Selection of the appropriate diluent depends on the downstream experimental assay requirements and the intended duration of use post-reconstitution.
For non-sterile in vitro assays requiring immediate use, sterile 0.9% sodium chloride or phosphate-buffered saline (PBS) may be selected. However, for multi-use laboratory containers requiring prolonged refrigeration over days or weeks, bacteriostatic water (containing 0.9% benzyl alcohol) is recommended to inhibit microbial growth. Researchers should consult the peptide reconstitution guide for exact stoichiometric calculations and step-by-step liquid handling practices. Gentle agitation via slow inversion should be used; high-shear vortexing must be avoided, as kinetic turbulence can disrupt secondary peptide structures and induce aggregation.
Post-Reconstitution Degradation Kinetics and Refrigeration Rules
Once dissolved, aqueous CJC-1295 DAC enters a continuous rate of thermodynamic decay influenced primarily by temperature, pH, and exposure to light. The peptide sequence contains amino acid residues susceptible to oxidation (particularly methionine) and deamidation (asparagine or glutamine residues), both of which alter molecular mass and structural conformation.
Reconstituted CJC-1295 DAC stored in bacteriostatic water at 2°C to 8°C demonstrates high structural fidelity for up to 14 to 21 days. Beyond this window, analytical purity may drop below experimental thresholds due to gradual hydrolysis. Maintaining the solution in a light-shielded amber container or wrapped in foil minimizes photo-oxidation, preserving peptide efficacy across multi-day laboratory assays.
Mitigating Freeze-Thaw Stress via Aliquoting Strategies
Freezing reconstituted peptide solutions slows chemical reaction rates to near zero, preserving long-term purity. However, the physical process of freezing and thawing subjects the peptide matrix to mechanical stress. Ice crystal nucleation can generate physical shear forces, while localized ice formation concentrates solutes and shifts pH, causing partial denaturation or irreversible molecular aggregation.
To prevent repetitive thermal cycling damage, researchers should implement an aliquoting strategy immediately following reconstitution. Reconstituted solutions should be divided into single-use microcentrifuge volumes using polypropylene tubes. These individual aliquots are then stored at -20°C or -80°C until needed. Once a single-use aliquot is thawed for analysis, any remaining residue should be refrigerated for short-term completion of the assay or discarded, rather than subjected to re-freezing.
Comparative Stability Analysis: CJC-1295 DAC vs. Related Secretagogues
Evaluating chemical handling across the GHRH and GH secretagogue class reveals crucial operational differences in physical stability and post-reconstitution half-life. Researchers frequently compare these molecules when establishing storage standards for long-term physiological studies.
When comparing CJC-1295 DAC to CJC-1295 Without DAC, the presence of the maleimide affinity complex adds a distinct reactive target that requires lower moisture exposure during storage. Meanwhile, non-DAC GHRH analogs like Tesamorelin exhibit different structural backbone variations that influence solubility and rate of oxidation in buffer solutions. Furthermore, ghrelin receptor agonists such as Ipamorelin possess distinct pentapeptide structures that demonstrate higher stability against physical shear during vortexing than longer 29-amino-acid GHRH derivatives. Standardizing peptide storage and handling protocols across all secretagogue classes ensures minimal cross-contamination and maintains experimental baseline accuracy.
PX1 Research Quality Assurance & Analytical Standards
To guarantee that researchers receive CJC-1295 DAC free from preexisting degradation or thermal stress, PX1 Research adheres to uncompromising quality control procedures. Every batch is synthesized in ISO 17025 accredited and GMP-compliant facilities within the United States.
Each lot undergoes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) verification to confirm purity levels above 98.0% and exact molecular weight verification. Additionally, routine endotoxin testing guarantees levels strictly under 0.1 EU/mg, minimizing confounding inflammatory variables in cell culture and animal models. All orders are packed in temperature-controlled packaging and shipped same-day from CA or AZ fulfillment centers (Monday through Friday), ensuring optimal cold-chain preservation from our facility to your laboratory bench.
Summary Protocol: Practical Laboratory Storage Framework
Maintaining consistency across research trials requires clear, standardized operational procedures for peptide handling. By integrating high-purity compounds with disciplined environmental management, research facilities prevent non-specific baseline variations across repeated trial blocks.
For institutional procurement and high-throughput research laboratories setting up bulk testing workflows, establishing a wholesale research account provides access to batch-consistent lots accompanied by comprehensive lot-specific Certificates of Analysis (COA). Adhering to the storage and reconstitutions protocols detailed above protects analytical investments and validates experimental data.
Frequently Asked Questions
How should lyophilized CJC-1295 DAC be stored upon arrival?
Upon arrival, lyophilized CJC-1295 DAC should be transferred immediately to a dry, temperature-controlled environment. For immediate use within 30 days, store at 2°C to 8°C. For long-term preservation, store at -20°C or -80°C in a desiccated container to prevent moisture absorption.
What is the shelf life of reconstituted CJC-1295 DAC at 2–8°C?
When reconstituted with bacteriostatic water containing 0.9% benzyl alcohol, CJC-1295 DAC maintains analytical stability for approximately 14 to 21 days at standard refrigeration temperatures (2°C to 8°C). Storing beyond this window increases the risk of hydrolytic decay.
Can reconstituted CJC-1295 DAC undergo multiple freeze-thaw cycles?
No. Repetitive freeze-thaw cycles induce mechanical stress from ice crystal formation and local pH shifts, causing peptide cleavage and aggregation. Researchers should divide freshly reconstituted peptide into single-use aliquots before initial freezing.
What diluent provides optimal stability for multi-use laboratory vials?
Bacteriostatic water (0.9% benzyl alcohol) is the optimal diluent for multi-use vials stored at 2°C to 8°C, as the benzyl alcohol agent prevents microbial contamination over a multi-week experimental testing period.
How does the DAC modification alter peptide handling compared to unmodified GHRH?
The Drug Affinity Complex (DAC) includes a reactive maleimide linker designed to bind serum albumin. Unreconstituted maleimide groups are sensitive to atmospheric humidity and thermal stress, requiring strict desiccation during storage before liquid reconstitution.
What signs indicate chemical degradation in reconstituted CJC-1295 DAC?
Physical indicators include cloudiness, visible precipitate, or changes in color. Chemical degradation like deamidation or oxidation may occur without visible signs, requiring HPLC or MS analysis to detect changes in purity.
What endotoxin thresholds are maintained for PX1 Research CJC-1295 DAC?
PX1 Research mandates that every batch of CJC-1295 DAC undergo chromogenic LAL testing to verify endotoxin levels below 0.1 EU/mg, preventing non-specific cell activation in preclinical research models.
Why is protection from light exposure critical for CJC-1295 DAC?
UV and ambient light exposure accelerate photo-oxidation of specific amino acid side chains (such as methionine and tryptophan), altering the primary sequence structure and reducing binding affinity in receptor assays.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.